The mission of the Immune Monitoring and Flow Cytometry (IMFC) SR is to support the Rutgers Cancer Institute cell therapy initiatives of the Nancy and Duncan MacMillan Center of Excellence, while offering integrated immunoprofiling, cell sorting, and cytometry services for clinical and basic applications to all Rutgers Cancer Institute members. The previously developing Immune Monitoring SR has been merged with the Flow Cytometry SR to allow for the modernization of Flow Cytometry and Cell Sorting services, their alignment with strategic expansion in Immunology and Cell Therapy, and to provide expanded personnel coverage. For more information on exciting new services and new instrumentation, please visit the “Services & Requests” and “Equipment” pages.
Christian Hinrichs, MD, FACS, serves as Faculty Director since January 2021. Dr. Hinrichs is a leader in tumor immunology and cancer immunotherapy. He also holds the positions of Chief of Cancer Immunotherapy Section and Co-director of the Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute in 2021.
Ankit Saxena, PhD, serves as Managing (staff) Director for the Rutgers University site since March 2022. Dr. Saxena consults with faculty for experimental design and resultant data interpretation using immunophenotyping, flow cytometry, and nucleic based assays at New Brunswick.
Christina DeCoste, continues as Managing (staff) Director for the Princeton University Flow Cytometry site, where she supports project design, operations, and training.
ACKNOWLEDGEMENT OF IMMUNE MONITORING AND FLOW CYTOMETRY SHARED RESOURCE
For work performed in the Immune Monitoring SR through 02/29/2024, please use the following acknowledgment:
"Services, results and/or products in support of the research project were generated by the Rutgers Cancer Institute of New Jersey Immune Monitoring Shared Resource, supported, in part, with funding from the NCI-CCSG P30CA072770-5931."
For work performed in the Flow Cytometry and Cell Sorting SR please continue to use the following acknowledgment:
"Services, results and/or products in support of the research project were generated by the Rutgers Cancer Institute of New Jersey Flow Cytometry and Cell Sorting Shared Resource, supported, in part, with funding from NCI-CCSG P30CA072720-5921."
Work that involves extensive assay and project design performed by the SR personnel should include them as co-authors in relevant publications.
NIH Public Access Policy: Publications that result from services provided by this Shared Resource must be compliant with the NIH Public Access policy by submitting your paper to PubMed Central. View Pubmed Central’s submission instructions.
Last updated 01/24/2023